hotspot
Previous article:
BioMarin wins approval for gene therapy to treat hemophilia A
Next article: Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs
Next article: Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs
knowledge
explore
-
Research misconduct: Proposed new rules face resistance
2025-09-27 22:06 -
Independent physicians launch a new lobbying group
2025-09-27 20:47 -
Medicare Advantage today, explained in one chart
2025-09-27 20:43 -
Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview
2025-09-27 20:20 -
Poland's lawmakers approve a divisive law on Russian influence
2025-09-27 20:17 -
Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources
2025-09-27 20:15